Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours

References

• Amichetti M., Graiff C., Fellin G., Pani G., Bolner A., Maluta S., Valdagni R. Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I–II study. International Journal of Radiation Oncology, Biology and Physics 1993; 26: 801–807
   PubMedGoogle Scholar
• Bornstein B. A., Zouranjian P. S., Hansen J. L., Fraser S. M., Gelwan L. A., Teicher B. A., Svensson G. K. Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma. International Journal of Radiation Oncology, Biology and Physics 1993; 25: 79–85
   PubMed Web of Science ®Google Scholar
• Buswell L., Recht A., Clark J., Ravikumar T., Busse P. M., Coleman C. N. Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole, and cisplatin-fluorouracil, with or without surgery: neurotoxicity, other toxicities and outcome. International Journal of Radiation Oncology, Biology and Physics 1994; 29: 535–540
   PubMedGoogle Scholar
• Coleman C. N., Urtasun R. C., Wasserman T. H., Hancock S., Harris J. W., Halsey J., Hirst V. K. Initial report of the phase I trial of the hypoxic cell radiosensitizer SR2508. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1749–1753
   PubMed Web of Science ®Google Scholar
• Coleman C. N., Halsey J., Cox R. S., Hirst V. K., Blaschke T., Howes A. E., Wasserman T. H., Urtasun R. C., Pajak T., Hancock S., Phillips T. L., Noll L. Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR2508 and the pharmacokinetic profile. Cancer Research 1987; 47: 319–322
   PubMedGoogle Scholar
• Coleman C. N., Wasserman T. H., Urtasun R. C., Halsey J., Noll L., Hancock S., Phillips T. L. Final report of the phase I trial of the hypoxic cell radiosensitizer SR2508 (etanidazole) Radiation Therapy Oncology Group 83–03. International Journal of Radiation Oncology, Biology and Physics 1990; 18: 389–393
   PubMed Web of Science ®Google Scholar
• Coleman C. N., Buswell L., Noll L., Riese N., Rose M-A. The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer. International Journal of Radiation Oncology, Biology and Physics 1992; 22: 565–568
   PubMedGoogle Scholar
• Dahl O. Interaction of hyperthermia and chemotherapy. Recent Results in Cancer Research 1988; 107: 157–169
   PubMedGoogle Scholar
• Denekamp J., Joiner M. C. The potential benefit from a perfect radiosensitizer and its dependence on reoxygenation. British Journal of Radiology 1982; 55: 657–663
   PubMedGoogle Scholar
• Hahn G. M. Potential for therapy of drugs and hyperthermia. Cancer Research 1979; 39: 2264–2268
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Jochelson M., Clark J., Svensson G., Coleman C. N. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. International Journal of Hyperthermia 1988; 4: 143–158
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A. Sequencing of trimodality therapy [cis-diamminedichloro-platinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Cancer Research 1988; 48: 2693–2697
   PubMed Web of Science ®Google Scholar
• Herman T. S., Jochelson M. S., Teicher B. A., Scott P. J., Hansen J., Clark J. R., Pfeffer M. R., Gelwan L. E., Molnar-Griffin B. J., Fraser S. M., Svensson G., Bornstein B. A., Ryan L., Coleman C. N. A Phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. International Journal of Radiation Oncology, Biology and Physics 1989; 17: 1273–1279
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Holden S. A., Pfeffer M. R., Jones S. M. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma. Cancer Research 1990; 50: 2734–2740
   PubMed Web of Science ®Google Scholar
• International Consensus Meeting on Hyperthermia, Final Report. International Journal of Hyperthermia 1990; 6: 837–877
   Google Scholar
• Kapp D. S., Barnett T. A., Cox R. S., Lee E. R., Lohrbach A., Fessenden P. Hyperthermia and radiation therapy of local-regional recurrent breast cancer: prognostic factors for response and local control of diffuse or nodular tumors. International Journal of Radiation Oncology, Biology and Physics 1991; 20: 1147–1164
   PubMed Web of Science ®Google Scholar
• Oleson J. R., Sim D. A., Manning M. R. Analysis of prognostic variables in hyperthermia treatment of 161 patients. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 2231–2239
   PubMed Web of Science ®Google Scholar
• Oleson J. R., Leopold K. A., Samulski T. V., George S. L., Dodge R. K., Grant W. J., Dewhirst M. W., Prosnitz L. P. Results of a phase II trial of HT + RT. Abstracts of Papers for the Thirty-eighth Annual Meeting of the Radiation Research Society. Louisiana, New Orleans 1990; 18
   Google Scholar
• Overgaard J. Rationale and problems in the design of clinical studiesHyperthermia Oncology. Review Lectures, Symposium Summaries and Workshop Summaries, J. Overgaard. Taylor and Francis, London 1984; Vol. 2: 325–338
   Google Scholar
• Overgaard J. The current and potential role of hyperthermia in radiotherapy. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 535–549
   PubMed Web of Science ®Google Scholar
• Overgaard J., Radacic M. M., Grau C. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo. Cancer Research 1991; 51: 707–711
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Herman T. S., Holden S. A. Combined modality therapy with bleomycin/hyperthermia/radiation. Cancer Research 1988; 48: 6291–6297
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Pfeffer M. R., Alvarez Sotomayor E., Herman T. S. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia and radiation. International Journal of Hyperthermia 1991; 7: 773–784
   PubMed Web of Science ®Google Scholar
• Valdagni R., Liu F. F., Kapp D. S. Important prognostic factors influencing outcome of combined radiation and hyperthermia. International Journal of Hyperthermia 1988; 15: 959–972
   Google Scholar